• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    MEDIROM launches cryptocurrency strategy with next-generation proof of human technology, "World"

    8/22/25 4:45:00 PM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary
    Get the next $MRM alert in real time by email

    image2

    TOKYO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. ((Headquarters: Minato-ku, Tokyo, CEO: Kouji Eguchi, NASDAQ:MRM) (the "Company", "we" or "us"), which operates a diversified healthcare business, announced its participation in "World," a "proof of human" protocol co-founded by Sam Altman and Alex Blania.

    The purpose of this project is to build a new digital infrastructure that will enable "proof of humanness" in the age of AI. As part of this project, we intend to install the World ID authentication device, the "Orb", in approximately 100 of our Re.Ra.Ku, relaxation salons. Our goal is to provide access to a verified World ID to a network of up to 500,000 individuals.

    In addition, those who verify their World ID can choose to claim the equivalent of approximately 8,000 Japanese yen in Worldcoin tokens ("WLD") (based on current WLD prices). Soon, customers will be able to use WLD to purchase gift certificates ("Re.Ra.Ku Tickets") that can be redeemed at Re.Ra.Ku relaxation salons.

    Once this program has launched, when customers purchase Re.Ra.Ku Tickets, the Company plans to acquire WLD. However, while considering the liquidity and balance sheet risks that the Company can tolerate on a case-by-case basis, the Company plans to exchange up to 50% of the acquired WLD for the cryptocurrency Ethereum (ETH) and hold it, while analyzing and managing the trends in the cryptocurrency market. Our goal is for these assets to enhance our future financial strategy and drive business expansion.

    Our Company aims to create new value and achieve sustainable growth by going beyond the scope of the healthcare business and integrating with next-generation digital infrastructure.

    About Re.Ra.Ku Group

    image3

    The Re.Ra.Ku Group operates over 300 relaxation salons across Japan, centered around the "Re.Ra.Ku" brand. In addition to "Re.Ra.Ku," which is located in commercial facilities and street-front shops, the group operates five other brands: "Spa Re.Ra.Ku," which operates hot spring facilities; "Re.Ra.Ku PRO," which operates multi-purpose running stations; "Bell Epoc," which offers a wide range of services including reflexology and aroma body care, mainly in rural areas; and "Ruam Ruam," which offers Asian-style therapy at luxury relaxation salons.

    A list of locations at which the Orb device has been installed: https://reraku.jp/studio/search?q=%7B%22prefectureId%22%3Anull%2C%22cityIds%22%3A%5B%5D%2C%22railroadLineIds%22%3A%5B%5D%2C%22railroadStationIds%22%3A%5B%5D%2C%22courseGenreIds%22%3A%5B%5D%2C%22particularConditionIds%22%3A%5B21%5D%2C%22q%22%3A%22%22%2C%22isLocationSearch%22%3Afalse%7D

    About the MEDIROM Group

    image3

    MEDIROM provides specific health guidance and physical improvement programs using the healthcare app "Lav," centered around its relaxation salon brand "Re.Ra.Ku" that aims to provide health management services. Furthermore, in 2020, the company entered the device business, releasing the "MOTHER Bracelet," an activity tracker that operates continuously without charging. Going forward, the Company intends to expand its business domain into data analysis based on lifestyle data accumulated since its founding.

    Overview of MEDIROM

    Company name: MEDIROM Healthcare Technologies Inc.

    Market: NASDAQ

    Ticker (US stock code): MRM (Nasdaq CM)

    Head office location: Trade Pier Odaiba 16F, 2-3-1 Odaiba, Minato-ku, Tokyo

    Representative: Representative Director Koji Eguchi

    Established: July 2000

    Contact Information

    MEDIROM Co., Ltd. Email: [email protected]

    Forward-Looking Statements

    Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about the Company's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company's operations, results of operations, growth strategy and liquidity. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this press release include:

    • the Company's ability to achieve its development goals for its business and execute and evolve its growth strategies, priorities and initiatives;
    • the Company's ability to achieve and sustain profitability in its Digital Preventative Healthcare Segment;
    • the fluctuation of foreign exchange rates, which affects the Company's expenses and liabilities payable in foreign currencies;
    • changes in demographic, unemployment, economic, regulatory or weather conditions affecting the Tokyo region of Japan, where the Company's relaxation salon base is geographically concentrated;
    • the Company's ability to maintain and enhance the value of its brands and to enforce and maintain its trademarks and protect its other intellectual property;
    • the Company's ability to raise additional capital on acceptable terms or at all;
    • the Company's level of indebtedness and potential restrictions on the Company under the Company's debt instruments;
    • the Company's ability to respond to natural disasters, such as earthquakes and tsunamis, and to global pandemics, such as COVID-19; and
    • the regulatory environment in which the Company operates.



    More information on these risks and other potential factors that could affect the Company's business, reputation, results of operations, financial condition, and stock price is included in the Company's filings with the Securities and Exchange Commission (the "SEC"), including in the "Risk Factors" and "Operating and Financial Review and Prospects" sections of the Company's most recently filed periodic report on Form 20-F and subsequent filings, which are available on the SEC website at www.sec.gov. The Company assumes no obligation to update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future.

    Photos accompanying this announcement are available at:

    https://www.globenewswire.com/NewsRoom/AttachmentNg/d908900f-e237-4d87-a073-b03de8606b88

    https://www.globenewswire.com/NewsRoom/AttachmentNg/856ca15e-8507-4c65-a6d9-4c46eb9a92e1

    https://www.globenewswire.com/NewsRoom/AttachmentNg/d894c976-144e-4569-8a72-1e0242787e89



    Primary Logo

    Get the next $MRM alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MRM

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MRM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Series A Round Valuation: ¥9 Billion: MEDIROM MOTHER Labs Inc. Decides to Make an Investment from Internal Investors

    TOKYO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- MEDIROM MOTHER Labs Inc. (Headquarters: Minato-ku, Tokyo; President and CEO: Yoshio Uekusa; hereinafter "MOTHER Labs"), a subsidiary of MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM), today announced that it has approved a private placement of new shares to two officers, Yoshio Uekusa, President and CEO, and Ryo Saito, Director, as part of its Series A financing round, at a valuation of JPY9 billion. Funding is scheduled to occur by the end of October. ◼︎Background for ImplementationMOTHER Labs serves as the health tech division within the MEDIROM Group, having previously implemented specific health guidance programs using the healthcare app "La

    10/9/25 8:00:00 AM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    Medirom Decides to Double Installation of Authentication Device "Orb" to 200 Stores, in Collaboration with "World" Co-founded by Sam Altman and Alex Blania

    TOKYO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. ((Headquarters: Minato-ku, Tokyo, CEO: Kouji Eguchi, NASDAQ:MRM), a diversified healthcare company, has joined "World," a "proof of human" protocol co-founded by Sam Altman and Tools for Humanity's CEO, Alex Blania. MEDIROM plans to complete the deployment of the World ID proof of human authentication device Orb across 100 of its Re.Ra.Ku relaxation studios in Japan within this month, and to expand the deployment to 200 locations nationwide further. This expansion marks the largest installation of Orbs in Japan to date, providing greater access to this new social infrastructure that enables individuals to prov

    9/25/25 5:30:00 PM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    Japan Ground Self-Defense Force Adopts MEDIROM MOTHER Labs' REMONY for Advanced Health Monitoring and Heatstroke Safety

    TOKYO, Sept. 18, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) ("MEDIROM") today announced that its subsidiary, MEDIROM MOTHER Labs Inc. ("MOTHER Labs"), has begun providing its remote health monitoring system "REMONY," powered by the recharge-free smart tracker MOTHER Bracelet®, to the Japan Ground Self-Defense Force (JGSDF).■Background of the Deployment In recent years, the importance of health management and heatstroke prevention for personnel operating under extreme conditions has grown significantly. Traditional wearable devices often face limitations in such environments—particularly in mountainous or remote areas where power supply is scarce—makin

    9/18/25 5:00:00 PM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    $MRM
    SEC Filings

    View All

    SEC Form 6-K filed by MEDIROM Healthcare Technologies Inc.

    6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)

    10/21/25 5:24:50 PM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    SEC Form 6-K filed by MEDIROM Healthcare Technologies Inc.

    6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)

    10/20/25 7:23:12 AM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    SEC Form 6-K filed by MEDIROM Healthcare Technologies Inc.

    6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)

    10/9/25 6:10:09 AM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    $MRM
    Leadership Updates

    Live Leadership Updates

    View All

    "NASDAQ JAPAN IR EVENT" to Be Held at Nasdaq MarketSite on June 20, 2024

    NEW YORK, May 20, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan ("MEDIROM", the "Company"), today announced it will participate in a "NASDAQ JAPAN IR EVENT" to be held at Nasdaq MarketSite in Times Square on June 20, 2024. Five companies are currently expected to join this event (including one private company), and we will share information about the attractive nature of the Japanese market with a global audience. PurposeIn December 2020, the Company became the first Japanese company in 21 years to list on Nasdaq. Today, the number of Japanese companies listed on Nasdaq has increased to eight. While more and mor

    5/20/24 3:00:00 PM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    $MRM
    Financials

    Live finance-specific insights

    View All

    MEDIROM Rehab Solutions Inc. Acquires Rehabilitation Centers from Y's, Inc.

    TOKYO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) ("Medirom" or the "Company") is pleased to announce that it is capitalizing on its extensive experience operating wellness clinics and healthcare technology to expand into the rehabilitation industry. In doing so, MEDIROM established a wholly-owned subsidiary, MEDIROM Rehab Solutions Inc., which acquired all of the rehabilitation centers of Y's, Inc. Prior to the acquisition by MEDIROM Rehab Solutions Inc., Y's, Inc. owned and operated ten cerebral infarction rehabilitation centers in Tokyo and other major cities across Japan. Cerebral infarction rehabilitation is a comprehensive program designed to

    10/7/24 4:00:00 PM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    MEDIROM Healthcare Technologies Inc. Announces Financial Results for Fiscal Year 2023

    TOKYO, June 25, 2024 (GLOBE NEWSWIRE) --  MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) ("Medirom" or the "Company"), a holistic healthcare company based in Japan, announced it filed its Annual Report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission ("SEC"), including consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP"), on June 18, 2024. Kouji Eguchi, Chief Executive Officer of the Company, stated, "I am very pleased to announce that during a period of significant investment and development in our healthcare technology systems and products in FY 2023 and FY 2022, as wel

    6/25/24 9:37:44 AM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    MEDIROM Healthcare Technologies Inc. Announces Preliminary 2021 Financial Results

    NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (the "Company"), today announced its preliminary unaudited financial results for the fiscal year ended December 31, 2021, prepared in accordance with U.S. GAAP. Due to additional time required to complete its year-end reporting process, the Company determined that it was unable to file its Annual Report on Form 20-F for the fiscal year ended December 31, 2021, within the prescribed time period without unreasonable effort and expense. The Company filed a Notification of Late Filing on Form 12b-25 with the U.S. Securities and Exchange Commission o

    5/13/22 7:53:59 AM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    $MRM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by MEDIROM Healthcare Technologies Inc.

    SC 13G - Medirom Healthcare Technologies Inc. (0001819704) (Subject)

    12/10/24 7:38:12 AM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    SEC Form SC 13D filed by MEDIROM Healthcare Technologies Inc.

    SC 13D - Medirom Healthcare Technologies Inc. (0001819704) (Subject)

    1/25/23 4:16:06 PM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary

    SEC Form SC 13D filed by MEDIROM Healthcare Technologies Inc.

    SC 13D - Medirom Healthcare Technologies Inc. (0001819704) (Subject)

    1/6/23 6:12:19 AM ET
    $MRM
    Other Consumer Services
    Consumer Discretionary